Search - tctmd.com

Displaying 201 - 220 of 586

Sort: Relevancy | Date

Presentation TCT 2014

Stent Designs and STEMI: Are There Meaningful Differences?

Presenter: Luigi Salemme, Mohamed Sobhy, Carlo Briguori

September 13, 2014

Presentation TCT 2014

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Presenter: Luigi Salemme, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

Multivessel PCI in ACS Supported by ECMO

Presenter: Vladimir Ganyukov

September 13, 2014

Presentation TCT 2014

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

Presenter: Frederick Feit, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

STEMI: Treatment Strategies, Drugs, and Devices

Presenter: Tayo A. Addo, Marc Etienne Jolicoeur

September 13, 2014

Presentation TCT 2014

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Jurrien M. Ten Berg

September 13, 2014

Presentation TCT 2014

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Presenter: Patrick W. Serruys, George D. Dangas

September 13, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi

September 13, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, Olivier Muller

September 13, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, Simon J. Walsh

September 13, 2014

Presentation TCT 2014

Case #2: Another High-Risk STEMI Patient

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, Olivier Muller

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi

September 13, 2014

Presentation TCT 2014

NSTE-ACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

September 13, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, John Cosgrave

September 13, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, Oliver Gaemperli

September 13, 2014

Presentation TCT 2014

Case #1: A High-Risk STEMI Patient

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, John Cosgrave

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Nick Curzen, Thomas Engstroem, Liliana R. Grinfeld, James Nolan

September 13, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Nick Curzen, Thomas Engstroem, Liliana R. Grinfeld, James Nolan, Lene Holmvang

September 13, 2014

Presentation TCT 2014

Case #3: RV Infarction After Inferior STEMI with Cardiogenic Shock

Presenter: Nick Curzen, Thomas Engstroem, Liliana R. Grinfeld, James Nolan, Lene Holmvang

September 13, 2014

Advertisement

Stent Designs and STEMI: Are There Meaningful Differences?

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Multivessel PCI in ACS Supported by ECMO

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

STEMI: Treatment Strategies, Drugs, and Devices

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Are GP IIb/IIIa Inhibitors Still Useful?

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #2: Another High-Risk STEMI Patient

Consensus and Take-home Messages

NSTE-ACS: Risk Stratification and Treatment

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #1: A High-Risk STEMI Patient

Consensus and Take-home Messages

How Did I Treat This Patient?

Case #3: RV Infarction After Inferior STEMI with Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content